Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Does Purdue’s Reformulated OxyContin ER Really Deter Abuse? US FDA Panel To Decide
Aug 25 2020
•
By
Brenda Sandburg
FDA advisory committee to review OxyContin ER abuse deterrent data • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers